Candida albicans secreted aspartyl proteinases in virulence and pathogenesis

Microbiology and Molecular Biology Reviews

Volumn 67, Issue 3, 2003, Pages 400-428

  Naglik, Julian R ^a   Challacombe, Stephen J ^a   Hube, Bernhard ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

A 70450; A 79912; ANTIFUNGAL AGENT; ASPARTIC PROTEINASE; ASPARTIC PROTEINASE INHIBITOR; FLUCONAZOLE; INDINAVIR; MUTANT PROTEIN; NELFINAVIR; PEPSTATIN; PEPTIDOMIMETIC AGENT; PHENOL DERIVATIVE; RENIN INHIBITOR; RITONAVIR; SAQUINAVIR; SERRATENE TRITERPENE; TRITERPENE DERIVATIVE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE; YAPSIN 1; YF 0200R A B; YF 044P D;

CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL MEMBRANE; DIGESTION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG SCREENING; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FUNGAL GENE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; NUTRIENT; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; STRUCTURE ANALYSIS; VIRULENCE;

ASPARTIC ENDOPEPTIDASES; CANDIDA ALBICANS; CANDIDIASIS; FUNGAL PROTEINS; HUMANS; VIRULENCE;

ANIMALIA; CANDIDA; CANDIDA ALBICANS;

EID: 0141789642     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.67.3.400-428.2003     Document Type: Review

References (261)

1. Abad-Zapatero, C., R. Goldman, S. W. Muchmore, C. Hutchins, K. Stewart, J. Navaza, C. D. Payne, and T. L. Ray. 1996. Structure of a secreted aspartic protease from C albicans complexed with a potent inhibitor: implications for the design of antifungal agents. Protein Sci. 5:640-652.
2. Abu-Elteen, K. H., A. Z. Elkarmi, and M. Hamad. 2001. Characterization of phenotype-based pathogenic determinants of various Candida albicans strains in Jordan. Jpn. J. Infect. Dis. 54:229-236.
3. Acosta, E. P., T. N. Kakuda, R. C. Brundage, P. L. Anderson, and C. V. Fletcher. 2000. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors. Clin. Infect. Dis. 30(Suppl. 2):S151-S159.
4. Agatensi, L., F. Franchi, F. Mondello, R. L. Bevilacqua, T. Ceddia, F. De Bernardis, and A. Cassone. 1991. Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J. Clin. Pathol. 44:826-830.
5. Apodaca, G., and J. H. McKerrow. 1990. Expression of proteolytic activity by cultures of Trichophyton rubrum. J. Med. Vet. Mycol. 28:159-171.
6. Barrett, A. J. 1980. Introduction: the classification of proteinases, p. 1-13. In Symposium on protein degradation in health and disease. Excerpta Medica, Amsterdam, The Netherlands.
7. Barrett, A. J., and N. D. Rawlings. 1991. Types and families of endopeptidases. Biochem. Soc. Trans. 19:707-715.
8. Beausejour, A., D. Grenier, J. P. Goulet, and N. Deslauriers. 1998. Proteolytic activation of the interleukin-1 beta precursor by Candida albicans. Infect. Immun. 66:676-681.
9. Beggah, S., U. Lechenne, U. Reichard, S. Foundling, and M. Monod. 2000. Intra- and intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p. Microbiology 146:2765-2773.
10. Bektic, J., C. P. Lell, A. Fuchs, H. Stoiber, C. Speth, C. Lass-Florl, M. Borg-von Zepelin, M. P. Dierich, and R. Wurzner. 2001. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol. Med. Microbiol. 31:65-71.
11. Berman, J., and P. E. Sudbery. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet. 3:918-930.
12. Borg, M., and R. Rüchel. 1988. Expression of extracellular acid proteinase by proteolytic Candida spp, during experimental infection of oral mucosa. Infect. Immun. 56:626-631.
13. Borg, M., and R. Rüchel. 1990. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis. J. Med. Vet. Mycol. 28:3-14.
14. Borg, M., D. Watters, B. Reich, and R. Rüchel. 1988. Production and characterization of monoclonal antibodies against secretory proteinase of Candida albicans CBS 2730. Zentbl. Bakteriol. Microbiol. Hyg. Ser. A 268:62-73.
15. Borg-von Zepelin, M., I. Meyer, R. Thomssen, R. Wurzner, D. Sanglard, A. Telenti, and M. Monod. 1999. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J. Investig. Dermatol. 113:747-751.
16. Borg-von Zepelin, M., S. Beggah, K. Boggian, D. Sanglard, and M. Monod. 1998. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol. Microbiol. 28:543-554.
17. Braun, B. R., and A. D. Johnson. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277:105-109.
18. Brown, A. J., and N. A. Gow. 1999. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol. 7:333-338.
19. Brown, A. J. P. 2002. Expression of growth-form specific factors during morphogenesis in Candida albicans, p. 87-93. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
20. Brown, A. J. P. 2002. Morphogenetic signaling pathways in Candida albicans, p. 95-106. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
21. Brueske, C. H. 1986. Proteolytic activity of a clinical isolate of Cryptococcus neoformans. J. Clin. Microbiol. 23:631-633.
22. Calderone, R., and N. A. R. Gow. 2002. Host recognition by Candida species, p. 67-86. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
23. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1-20.
24. Calderone, R. A., and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9:327-335.
25. Camilli, A., D. T. Beattie, and J. J. Mekalanos. 1994. Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA 91:2634-2638.
26. Capobianco, J. O., C. G. Lerner, and R. C. Goldman. 1992. Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase. Anal. Biochem. 204:96-102.
27. Caro, L. H., H. Tettelin, J. H. Vossen, A. F. Ram, H. van den Ende, and F. M. Klis. 1997. In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae. Yeast 13:1477-1489.
28. Cassone, A., F. De Bernardis, F. Mondello, T. Ceddia, and L. Agatensi. 1987. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis. 156:777-783.
29. Cassone, A., F. De Bernardis, A. Torosantucci, E. Tacconelli, M. Tumbarello, and R. Cauda. 1999. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J. Infect. Dis. 180:448-453.
30. Cassone, A., E. Tacconelli, F. De Bernardis, M. Tumbarello, A. Torosantucci, P. Chiani, and R. Cauda. 2002. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J. Infect. Dis. 185:188-195.
31. Cauda, R., E. Tacconelli, M. Tumbarello, G. Morace, De, F. Bernardis, A. Torosantucci, and A. Cassone. 1999. Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study. J. Acquir. Immun. Defic. Syndr. 21:20-25.
32. Cawley, N. X., M. Chino, A. Maldonado, Y. M. Rodriguez, Y. P. Loh, and J. A. Ellman. 2003. Synthesis and characterization of the first potent inhibitor of yapsin 1. Implications for the study of yapsin-like enzymes. J. Biol. Chem. 278:5523-5530.
33. Chaffin, W. L., J. L. Lopez-Ribot, M. Casanova, D. Gozalbo, and J. P. Martinez. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:130-180.
34. Challacombe, S. J., J. Muir, S. A. Howell, and S. P. Sweet. 1995. Genetic variability of Candida albicans in HIV infection. Microb. Ecol. Health Dis. 8:63-70.
35. Choi, G. H., D. M. Pawlyk, B. Rae, R. Shapira, and D. L. Nuss. 1993. Molecular analysis and overexpression of the gene encoding endothiapepsin, an aspartic protease from Cryphonectria parasitica. Gene 125:135-141.
36. Colina, A. R., F. Aumont, N. Deslauriers, P. Belhumeur, and L. de Repentigny. 1996. Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase. Infect. Immun. 64:4514-4519.
37. Coogan, M. M., S. P. Sweet, and S. J. Challacombe. 1994. Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect. Immun. 62:892-896.
38. Cowen, L. E., A. Nantel, M. S. Whiteway, D. Y. Thomas, D. C. Tessier, L. M. Kohn, and J. B. Anderson. 2002. Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA 99:9284-9289.
39. Cutfield, S. M., E. J. Dodson, B. F. Anderson, P. C. Moody, C. J. Marshall, P. A. Sullivan, and J. F. Cutfield. 1995. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3:1261-1271.
40. Cutler, J. E. 1991. Putative virulence factors of Candida albicans. Annu. Rev. Microbiol. 45:187-218.
41. Davies, D. R. 1990. The structure and function of aspartic proteinases. Annu. Rev. Biophys. Biophys. Chem. 19:189-215.
42. De Backer, M. D., T. Hyina, X. J. Ma, S. Vandoninck, W. H. Luyten, and H. Vanden Bossche. 2001. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45:1660-1670.
43. De Bernardis, F., L. Agatensi, L. K. Ross, G. W. Emerson, R. Lorenzini, P. A. Sullivan, and A. Cassone. 1990. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. J. Infect. Dis. 161:1276-1283.
44. De Bernardis, F., S. Arancia, L. Morelli, B. Hube, Sanglard, W. Schafer, and A. Cassone. 1999. Evidence that members of the secretory aspartyl proteinase gene family, in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. 179:201-208.
45. De Bernardis, F., M. Boccanera, D. Adriani, E. Spreghini, G. Santoni, and A. Cassone. 1997. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65:3399-3405.
46. De Bernardis, F., M. Boccanera, L. Rainaldi, C. E. Guerra, I. Quinti, and A. Cassone. 1992. The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HIV-infected subjects. Eur. J. Epidemiol. 8:362-367.
47. De Bernardis, F., A. Cassone, J. Sturtevant, and R. Calderone. 1995. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect. Immun. 63:1887-1892.
48. De Bernardis, F., P. Chiani, M. Ciccozzi, G. Pellegrini, T. Ceddia, G. D'Offizzi, I. Quinti, P. A. Sullivan, and A. Cassone. 1996. Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect. Immun. 64:466-471.
49. De Bernardis, F., F. Mondello, G. Scaravelli, A. Pachi, A. Girolamo, L. Agatensi, and A. Cassone. 1999. High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women. J. Clin. Microbiol. 37:1376-1380.
50. De Bernardis, F., P. A. Sullivan, and A. Cassone. 2001. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med. Mycol. 39:303-313.
51. de Chastellier, C., and P. Berche. 1994. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect. Immun. 62:543-553.
52. de Repentigny, L., F. Aumont, K. Bernard, and P. Belhumeur. 2000. Characterization of binding of Candida albicans to small intestinal mucin and its role in adherence to mucosal epithelial cells. Infect. Immun. 68:3172-3179.
53. de Viragh, P. A., D. Sanglard, G. Togni, R. Falchetto, and M. Monod. 1993. Cloning and sequencing of two Candida parapsilosis genes encoding acid proteases. J. Gen. Microbiol. 139:335-342.
54. Diz Dios, P., A. Ocampo, C. Miralles, I. Otero, I. Iglesias, and N. Rayo. 1999. Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 87:437-441.
55. Diz Dios, P., I. Otero, I. Iglesias, A. Ocampo, and C. Martinez. 1999. Failure of indinavir to inhibit Candida albicans in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 18:755-756.
56. Diz Dios, P., A. Ocampo, I. Iglesias, and I. Otero. 1999. Lack of ritonavir antifungal effect in vitro. Antimicrob. Agents Chemother. 43:997.
57. Drobacheff, C., L. Millon, M. Monod, R. Piarroux, E. Robinet, R. Laurent, and D. Meillet. 2001. Increased serum and salivary immunoglobulins against Candida albicans in HIV-infected patients with oral candidiasis. Clin. Chem. Lab Med. 39:519-526.
58. Edison, A. M., and M. Manning-Zweerink. 1988. Comparison of the extra-cellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent. Infect. Immun. 56:1388-1390.
59. Edmond, M. B., S. E. Wallace, D. K. McClish, M. A. Pfaller, R. N. Jones, and R. P. Wenzel. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
60. el-Maghrabi, E. A., D. M. Dixon, and J. W. Burnett. 1990. Characterization of Candida albicans epidermolytic proteases and their role in yeast-cell adherence to keratinocytes. Clin. Exp. Dermatol. 15:183-191.
61. Enjalbert, B., A. Nantel, and M. Whiteway. 2003. Stress-induced gene expression in Candida albicans: absence of a general stress response. Mol. Biol. Cell 14:1460-1467.
62. Ernst, J. F. 2000. Regulation of dimorphism in Candida albicans. Contrib. Microbiol. 5:98-111.
63. Ernst, J. F. 2000. Transcription factors in Candida albicans-environmental control of morphogenesis. Microbiology 146:1763-1774.
64. Fallon, K., K. Bausch, J. Noonan, E. Huguenel, and P. Tamburini. 1997. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect. Immun. 65:551-556.
65. Felk, A., M. Kretschmar, A. Albrecht, M. Schaller, S. Beinhauer, T. Nichterlein, D. Sanglard, H. C. Korting, W. Schafer, and B. Hube. 2002. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect. Immun. 70:3689-3700.
66. Felk, A., W. Schafer, and B. Hube. 2000. Candida albicans secretory aspartic proteinase (SAP10) gene. Accession number AF146440.
67. Filler, S. G., A. S. Pfunder, B. J. Spellberg, J. P. Spellberg, and J. E. Edwards, Jr. 1996. Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect. Immun. 64:2609-2617.
68. Filler, S. G., J. N. Swerdloff, C. Hobbs, and P. M. Luckett. 1995. Penetration and damage of endothelial cells by Candida albicans. Infect. Immun. 63:976-983.
69. Finlay, B. B., and S. Falkow. 1989. Common themes in microbial pathogenicity. Microbiol. Rev. 53:210-230.
70. Fradin, C., M. Kretschmar, T. Nichterlein, C. Gaillardin, C. d'Enfert, and B. Hube. 2003. Stage-specific gene expression of Candida albicans in human blood. Mol. Microbiol. 47:1523-1543.
71. Fusek, M., E. A. Smith, M. Monod, B. M. Dunn, and S. I. Foundling. 1994. Extracellular aspartic proteinases from Candida albicans, Candida tropicalis, and Candida parapsilosis yeasts differ substantially in their specificities. Biochemistry 33:9791-9799.
72. Gale, C. A., C. M. Bendel, M. McClellan, M. Hauser, J. M. Becker, J. Berman, and M. K. Hostetter. 1998. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355-1358.
73. Germaine, G. R., and L. M. Tellefson. 1981. Effect of pH and human saliva on protease production by Candida albicans. Infect. Immun. 31:323-326.
74. Ghadjari, A., R. C. Matthews, and J. P. Burnie. 1997. Epitope mapping Candida albicans proteinase (SAP 2). FEMS Immunol. Med. Microbiol. 19:115-123.
75. Ghannoum, M., and K. Abu Elteen. 1986. Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans. J. Med. Vet. Mycol. 24:407-413.
76. Ghannoum, M. A. 2000. Potential role of phospholipases in virulence and fungal pathogenesis. Clin. Microbiol. Rev. 13:122-143.
77. Gilfillan, G. D., D. J. Sullivan, K. Haynes, T. Parkinson, D. C. Coleman, and N. A. R. Gow. 1998. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144:829-838.
78. Goffeau, A., B. G. Barrell, H. Bussey, R. W. Davis, B. Dujon, H. Feldmann, F. Galibert, J. D. Hoheisel, C. Jacq, M. Johnston, E. J. Louis, H. W. Mewes, Y. Murakami, P. Philippsen, H. Tettelin, and S. G. Oliver. 1996. Life with 6000 genes. Science. 274:546, 563-546, 567.
79. Goldman, R. C., D. J. Frost, J. O. Capobianco, S. Kadam, R. R. Rasmussen, and C. Abad-Zapatero. 1995. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis. Infect. Agents Dis. 4:228-247.
80. Gow, N. A. R., A. J. P. Brown, and F. C. Odds. 2002. Fungal morphogenesis and host invasion. Curr. Opin. Microbiol. 5:366-371.
81. Gruber, A., J. Berlit, C. Speth, C. Lass-Florl, G. Kofler, M. Nagl, M. Borg von Zepelin, M. P. Dierich, and R. Wurzner. 1999. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors. Immunobiology 201:133-144.
82. Gruber, A., C. P. Lell, C. Speth, H. Stoiber, C. Lass-Florl, A. Sonneborn, J. F. Ernst, M. P. Dierich, and R. Wurzner. 2001. Human immunodeficiency virus type 1 Tat binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro. Immunology 104:455-461.
83. Gruber, A., E. Lukasser-Vogl, M. Borg von Zepelin, M. P. Dierich, and R. Wurzner. 1998. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Dis. 177:1057-1063.
84. Gruber, A., C. Speth, E. Lukasser-Vogl, R. Zangerle, M. Borg von Zepelin, M. P. Dierich, and R. Wurzner. 1999. Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro. Immunopharmacology 41:227-234.
85. Han, Y., and J. E. Cutler. 1995. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:2714-2719.
86. Han, Y., R. P. Morrison, and J. E. Cutler. 1998. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. 66:5771-5776.
87. Han, Y., M. H. Riesselman, and J. E. Cutler. 2000. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68:1649-1654.
88. Hannula, J., M. Saarela, B. Dogan, J. Paatsama, P. Koukila-Kahkola, S. Pirinen, H. L. Alakomi, J. Perheentupa, and S. Asikainen. 2000. Comparison of virulence factors of oral Candida dubliniensis and Candida albicans isolates in healthy people and patients with chronic candidosis. Oral Microbiol. Immunol. 15:238-244.
89. Hoegl, L., M. Ollert, and H. C. Korting. 1996. The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J. Mol. Med. 74:135-142.
90. Hoegl, L., E. Thoma-Greber, M. Rocken, and H. C. Korting. 1998. HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study. Mycoses 41:321-325.
91. Hoetelmans, R. M., M. van Essenberg, P. L. Meenhorst, J. W. Mulder, and J. H. Beijnen. 1997. Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. Ser. B 698:235-241.
92. Homma, M., H. Chibana, and K. Tanaka. 1993. Induction of extracellular proteinase in Candida albicans. J. Gen. Microbiol. 139:1187-1193.
93. Hood, S., A. Bonington, J. Evans, and D. Denning. 1998. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors. AIDS 12:447-448.
94. Hostetter, M. K. 1994. Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev. 7:29-42.
95. Hube, B. 1996. Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycolo. 7:55-69.
96. Hube, B. 2000. Extracellular proteinases of human pathogenic fungi, p. 126-137. In J. F. Ernst and A. Schmidt (ed.), Contributions to microbiology. Dimorphism in human pathogenic and apathogenic yeasts. S. Karger AG, Basel, Switzerland.
97. Hube, B., M. Monod, D. A. Schofield, A. J. P. Brown, and N. A. R. Gow. 1994. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol. Microbiol. 14:87-99.
98. Hube, B., and J. Naglik. 2001. Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147:1997-2005.
99. Hube, B., and J. R. Naglik. 2002. Extracellular hydrolases, p. 107-122. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
100. Hube, B., D. Sanglard, M. Monod, A. J. P. Brown, and N. A. R. Gow. 1997. Extracellular proteolytic activity of Candida species, p. 109-122. In H. Vanden Bossche, D. A. Stevens, and F. C. Odds (ed.), Host-fungus interplay. Proceedings of the Fifth Symposium on Topics in Mycology, 1995. National Foundation for Infectious Diseases, Bethesda, Md.
101. Hube, B., D. Sanglard, F. C. Odds, D. Hess, M. Monod, W. Schafer, A. J. Brown, and N. A. Gow. 1997. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence. Infect. Immun. 65:3529-3538.
102. Hube, B., C. J. Turver, F. C. Odds, H. Eiffert, G. J. Boulnois, H. Kochel, and R. Ruchel. 1991. Sequence of the Candida albicans gene encoding the secretory aspartate proteinase. J. Med. Vet. Mycol. 29:129-132.
103. Ibrahim, A. S., S. G. Filler, M. A. Ghannoum, and J. E. Edwards, Jr. 1993. Interferon-γ protects endothelial cells from damage by Candida albicans. J. Infect. Dis. 167:1467-1470.
104. Ibrahim, A. S., S. G. Filler, D. Sanglard, J. E. J. Edwards, and B. Hube. 1998. Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells. Infect. Immun. 66:3003-3005.
105. Jaton-Ogay, K., S. Paris, M. Huerre, M. Quadroni, R. Falchetto, G. Togni, J. P. Latge, and M. Monod. 1994. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol. Microbiol. 14:917-928.
106. Kaminishi, H., H. Hamatake, T. Cho, T. Tamaki, N. Suenaga, T. Fujii, Y. Hagihara, H. Maeda, S. H. Miyasaki, T. C. White, and N. Agabian. 1994. Activation of blood clotting factors by microbial proteinases. FEMS Microbiol. Lett. 176:1702-1710.
107. Kaminishi, H., H. Miyaguchi, T. Tamaki, N. Suenaga, M. Hisamatsu, I. Mihashi, H. Matsumoto, H. Maeda, and Y. Hagihara. 1995. Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun. 63:984-988.
108. Kaminishi, H., M. Tanaka, T. Cho, H. Maeda, and Y. Hagihara. 1990. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase. Infect. Immun. 58:2139-2143.
109. Kaufmann, S. H. 1990. Heat shock proteins and the immune response. Immunol. Today 11:129-136.
110. Kilian, M., J. Mestecky, and M. W. Russell. 1988. Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol. Rev. 52:296-303.
111. Kimura, L. H., and N. N. Pearsall. 1978. Adherence of Candida albicans to human buccal epithelial cells. Infect. Immun. 21:64-68.
112. Kimura, L. H., and N. N. Pearsall. 1980. Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells. Infect. Immun. 28:464-468.
113. Kirkpatrick, C. H., R. R. Rich, and J. E. Bennett. 1971. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann. Intern. Med. 74:955-978.
114. Klar, A. J., T. Srikantha, and D. R. Soll. 2001. A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. Genetics 158:919-924.
115. Klotz, S. A., D. J. Drutz, J. L. Harrison, and M. Huppert. 1983. Adherence and penetration of vascular endothelium by Candida yeasts. Infect. Immun. 42:374-384.
116. Koelsch, G., J. Tang, J. A. Loy, M. Monod, K. Jackson, S. I. Foundling, and X. Lin. 2000. Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim. Biophys. Acta 1480:117-131.
117. Kondoh, Y., K. Shimizu, and K. Tanaka. 1987. Proteinase production and pathogenicity of Candida albicans. II. Virulence for mice of C. albicans strains of different proteinase activity. Microbiol. Immunol. 31:1061-1069.
118. Korting, H. C., M. Schaller, G. Eder, G. Hamm, U. Bohmer, and B. Hube. 1999. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob. Agents Chemother. 43:2038-2042.
119. Krause, R., E. Schwab, D. Bachhiesl, F. Daxbock, C. Wenisch, G. J. Krejs, and E. C. Reisinger. 2001. Role of Candida in antibiotic-associated diarrhea. J. Infect. Dis. 184:1065-1069.
120. Kretschmar, M., A. Felk, P. Staib, M. Schaller, D. Hess, M. Callapina, J. Morschhauser, W. Schafer, H. C. Korting, H. Hof, B. Hube, and T. Nichterlein. 2002. Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. Microb. Pathog. 32:61-70.
121. Kretschmar, M., B. Hube, T. Bertsch, D. Sanglard, R. Merker, M. Schroder, H. Hof, and T. Nichterlein. 1999. Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect. Immun. 67:6637-6642.
122. Kvaal, C., S. A. Lachke, T. Srikantha, K. Daniels, J. McCoy, and D. R. Soll. 1999. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect. Immun. 67:6652-6662.
123. Kwon-Chung, K. J., D. Lehman, C. Good, and P. T. Magee. 1985. Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect. Immun. 49:571-575.
124. Lane, S., C. Birse, S. Zhou, R. Matson, and H. Liu. 2001. DNA array studies demonstrate convergent regulation of virulence factors by Cph1, Cph2, and Efg1 in Candida albicans. J. Biol. Chem. 276:48988-48996.
125. Leidich, S. D., A. S. Ibrahim, Y. Fu, A. Koul, C. Jessup, Vitullo, W. Fonzi, F. Mirbod, S. Nakashima, Y. Nozawa, and M. A. Ghannoum. 1998. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J. Biol. Chem. 273:26078-26086.
126. Lerner, C. G., and R. C. Goldman. 1993. Stimuli that induce production of Candida albicans extracellular aspartyl proteinase. J. Gen. Microbiol. 139:1643-1651.
127. Liljemark, W. F., and R. J. Gibbons. 1973. Suppression of Candida albicans by human oral streptococci in gnotobiotic mice. Infect. Immun. 8:846-849.
128. Liu, H. 2001. Transcriptional control of dimorphism in Candida albicans. Curr. Opin. Microbiol. 4:728-735.
129. Liu, H., J. Kohler, and G. R. Fink. 1994. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266:1723-1726.
130. Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
131. Lupetti, A., G. Guzzi, A. Paladini, K. Swart, M. Campa, and S. Senesi. 1995. Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J. Clin. Microbiol. 33:1238-1242.
132. Macdonald, F. 1984. Secretion of inducible proteinase by pathogenic Candida species. Sabouraudia 22:79-82.
133. Macdonald, F., and F. C. Odds. 1980. Inducible proteinase of Candida albicans in diagnostic serology and in the pathogenesis of systemic candidosis. J. Med. Microbiol. 13:423-435.
134. Macdonald, F., and F. C. Odds. 1980. Purified Candida albicans proteinase in the serological diagnosis of systemic candidosis. JAMA 243:2409-2411.
135. Macdonald, F., and F. C. Odds. 1983. Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J. Gen. Microbiol. 129:431-438.
136. Magee, P. T., and S. Scherer. 1998. Genome mapping and gene discovery in Candida albicans. ASM News 64:505-511.
137. Mathaba, L. T., A. E. Paxman, P. B. Ward, D. A. Forbes, and J. R. Warmington. 2000. Genetically distinct strains of Candida albicans with elevated secretory proteinase production are associated with diarrhoea in hospitalized children. J. Gastroenterol. Hepatol. 15:53-60.
138. Mathur, S., G. V. Koistinen, E. O. Horger, T. A. Mahvi, and H. H. Fudenberg. 1977. Humoral immunity in vaginal candidiasis. Infect. Immun. 15:287-294.
139. Matthews, R. C., J. P. Burnie, D. Howat, T. Rowland, and F. Walton. 1991. Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology 74:20-24.
140. Matthews, R. C., J. P. Burnie, and S. Tabaqchali. 1984. Immunoblot analysis of the serological response in systemic candidosis. Lancet ii:1415-1418.
141. McCullough, M. J., B. C. Ross, B. D. Dwyer, and P. C. Reade. 1994. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140:1195-1202.
142. McKerrow, J. H., E. Sun, P. J. Rosenthal, and J. Bouvier. 1993. The proteases and pathogenicity of parasitic protozoa. Annu. Rev. Microbiol. 47:821-853.
143. Millon, L., C. Drobacheff, R. Piarroux, M. Monod, G. Reboux, R. Laurent, and D. Meillet. 2001. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinases in HIV-infected patients. J. Acquir. Immune Defic. Syndr. 26:137-144.
144. Miyasaki, S. H., J. B. Hicks, D. Greenspan, I. Polacheck, L. A. MacPhail, T. C. White, N. Agabian, and J. S. Greenspan. 1992. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J. Acquir. Immune Defic. Syndr. 5:1039-1046.
145. Miyasaki, S. H., T. C. White, and N. Agabian. 1994. A fourth secreted aspartyl proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans. J. Bacteriol. 176:1702-1710.
146. Monod, M., and M. Borg-von Zepelin. 2002. Secreted proteinases and other virulence mechanisms of Candida albicans. Chem. Immunol. 81:114-128.
147. Monod, M., B. Hube, D. Hess, and D. Sanglard. 1998. Differential regulation of SAP8 and SAP9, which encode two new members of the secreted aspartic proteinase family in Candida albicans. Microbiology 144:2731-2737.
148. Monod, M., G. Togni, B. Hube, and D. Sanglard. 1994. Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Mol. Microbiol. 13:357-368.
149. Morrison, C. J., S. F. Hurst, S. L. Bragg, R. J. Kuykendall, H. Diaz, D. W. McLaughlin, and E. Reiss. 1993. Purification and characterization of the extracellular aspartyl proteinase of Candida albicans: removal of extraneous proteins and cell wall mannoprotein and evidence for lack of glycosylation. J. Gen. Microbiol. 139:1177-1186.
150. Morrow, B., H. Ramsey, and D. R. Soll. 1994. Regulation of phase-specific genes in the more general switching system of Candida albicans strain 3153A. J. Med. Vet. Mycol. 32:287-294.
151. Morrow, B., T. Srikantha, J. Anderson, and D. R. Soll. 1993. Coordinate regulation of two opaque-phase-specific genes during white-opaque switching in Candida albicans. Infect. Immun. 61:1823-1828.
152. Morrow, B., T. Srikantha, and D. R. Soll. 1992. Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans. Mol. Cell. Biol. 12:2997-3005.
153. Morschhauser, J., R. Virkola, T. K. Korhonen, and J. Hacker. 1997. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans. FEMS Microbiol. Lett. 153:349-355.
154. Murad, A. M., C. d'Enfert, C. Gaillardin, H. Tournu, F. Tekaia, D. Talibi, D. Marechal, V. Marchais, J. Cottin, and A. J. Brown. 2001. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol. Microbiol. 42:981-993.
155. Murad, A. M., P. Leng, M. Straffon, J. Wishart, S. Macaskill, D. MacCallum, N. Schnell, D. Talibi, D. Marechal, F. Tekaia, C. d'Enfert, C. Gaillardin, F. C. Odds, and A. J. Brown. 2001. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J. 20:4742-4752.
156. Murphy, J. M., and J. D. Walton. 1996. Three extracellular proteases from Cochliobolus carbonum: cloning and targeted disruption of ALP1. Mol. Plant-Microbe Interact 9:290-297.
157. Naglik, J. R., G. Newport, T. C. White, L. L. Fernandes-Naglik, J. S. Greenspan, D. Greenspan, S. P. Sweet, S. J. Challacombe, and N. Agabian. 1999. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67:2482-2490.
158. Naglik, J. R., C. A. Rodgers, P. J. Shirlaw, J. L. Dobbie, L. L. Fernandes-Naglik, D. Greenspan, N. Agabian, and S. J. Challacombe. 2003. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J. Infect. Dis. 188:465-475.
159. Nantel, A., D. Dignard, C. Bachewich, D. Harcus, A. Marcil, A. P. Bouin, C. W. Sensen, H. Hogues, H. M. Van Het, P. Gordon, T. Rigby, F. Benoit, D. C. Tessier, D. Y. Thomas, and M. Whiteway. 2002. Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol. Biol. Cell 13:3452-3465.
160. Newport, G., and N. Agabian. 1997. KEX2 influences Candida albicans proteinase secretion and hyphal formation. J. Biol. Chem. 272:28954-28961.
161. Odds, F. C. 1994. Candida species and virulence. ASM News 60:313-318.
162. Odds, F. C. 1994. Pathogenesis of Candida infections. J. Am. Acad. Dermatol. 31:S2-S5.
163. Odds, F. C. 2000. Pathogenic fungi in the 21st century. Trends Microbiol. 8:200-201.
164. Ogrydziak, D. M. 1993. Yeast extracellular proteases. Crit. Rev. Biotechnol. 13:1-55.
165. Ohkuma, S., and B. Poole. 1978. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. USA 75:3327-3331.
166. Ollert, M. W., R. Sohnchen, H. C. Korting, U. Ollert, S. Brautigam, and W. Brautigam. 1993. Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes. Infect. Immun. 61:4560-4568.
167. Ollert, M. W., C. Wende, M. Gorlich, C. G. McMullan-Vogel, M. Borg-von Zepelin, C. W. Vogel, and H. C. Korting. 1995. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J. Clin. Microbiol. 33:2543-2549.
168. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, and R. P. Wenzel. 1998. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 31:327-332.
169. Pichova, I., L. Pavlickova, J. Dostal, E. Dolejsi, O. Hruskova-Heidingsfeldova, J. Weber, T. Ruml, and M. Soucek. 2001. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur. J. Biochem. 268:2669-2677.
170. Powderly, W. G. 1992. Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6:604-605.
171. Qureshi, M. N., C. E. Barr, T. Seshamma, J. Reidy, R. J. Pomerantz, and O. Bagasra. 1995. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 171:190-193.
172. Rams, T. E., M. J. Andriolo, D. Feik, S. N. Abel, T. M. McGivern, and J. Slots. 1991. Microbiological study of HIV-related periodontitis. J. Periodontol. 62:74-81.
173. Ray, T. L., and C. D. Payne. 1987. Detection of Candida acid proteinase (CAP) antibodies in systemic candidiasis by enzyme immunoassay. Clin. Res. 35:711.
174. Ray, T. L., and C. D. Payne. 1988. Scanning electron microscopy of epidermal adherence and cavitation in murine candidiasis: a role for Candida acid proteinase. Infect. Immun. 56:1942-1949.
175. Ray, T. L., C. D. Payne, R. Ruchel, B. Ritter, and M. Schaffrinski. 1990. Comparative production and rapid purification of Candida acid proteinase from protein-supplemented cultures. Infect. Immun. 273:391-403.
176. Redding, S., J. Smith, G. Farinacci, M. Rinaldi, Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
177. Reichard, U., M. Monod, F. Odds, and R. Ruchel. 1997. Virulence of an aspergillopepsin-deficient mutant of Aspergillus fumigatus and evidence for another aspartic proteinase linked to the fungal cell wall. J. Med. Vet. Mycol. 35:189-196.
178. Remold, H., H. Fasold, and F. Staib. 1968. Purification and characterization of a proteolytic enzyme from Candida albicans. Biochim. Biophys. Acta 167:399-406.
179. Ripeau, J. S., M. Fiorillo, F. Aumont, P. Belhumeur, and L. de Repentigny. 2002. Evidence for differential expression of Candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice. J. Infect. Dis. 185:1094-1102.
180. Rogers, P. D., and K. S. Barker. 2002. Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob. Agents Chemother. 46:3412-3417.
181. Ross, I. K., F. De Bernardis, G. W. Emerson, A. Cassone, and P. A. Sullivan. 1990. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant. J. Gen. Microbiol. 136:687-694.
182. Reference deleted.
183. Rüchel, R. 1981. Properties of a purified proteinase from the yeast Candida albicans. Biochim. Biophys. Acta 659:99-113.
184. Rüchel, R. 1983. On the renin-like activity of Candida proteinases and activation of blood coagulation in vitro. Zentbl. Bakteriol. Mikrobiol. Hyg. Orig. A 255:368-379.
185. Rüchel, R. 1986. Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol. Sci. 3:316-319.
186. Rüchel, R. 1992. Proteinase, p. 17-31. In J. E. Bennett, R. J. Hay, and P. K. Peterson (ed.), New strategies in fungal disease. Churchill Livingstone, Edinburgh, United Kingdom.
187. Rüchel, R., B. Boning-Stutzer, and A. Mari. 1988. A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data. Mycoses 31:87-106.
188. Rüchel, R. and B. Boning. 1983. Detection of Candida proteinase by enzyme immunoassay and interaction of the enzyme with alpha-2-macroglobulin. J. Immunol. Methods 61:107-116.
189. Rüchel, R., B. Ritter, and M. Schaffrinski. 1990. Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentbl. Bakteriol. 273:391-403.
190. Rüchel, R., K. Uhlemann, and B. Boning. 1983. Secretion of acid proteinases by different species of the genus Candida. Zentbl. Bakteriol. Mikrobiol. Hyg. Orig. A 255:537-548.
191. Rüchel, R., F. Zimmermann, B. Boning-Stutzer, and U. Helmchen. 1991. Candidiasis visualised by proteinase-directed immunofluorescence. Virchows Arch. Ser. A 419:199-202.
192. Rupniak, H. T., C. Rowlatt, E. B. Lane, J. G. Steele, Trejdosiewicz, LK, B. Laskiewicz, S. Povey, and B. T. Hill. 1985. Characteristics of four new human cell lines derived from squamous cell carcinomas of the head and neck. J. Natl. Cancer Inst. 75:621-635.
193. Salyers, A., and D. Witt. 1994. Virulence factors that promote colonization, p. 30-46. In A. Salyers and D. Witt (ed.), Bacterial pathogenesis: a molecular approach. ASM Press, Washington, D.C.
194. Samaranayake, Y. H., and L. P. Samaranayake. 2001. Experimental oral candidiasis in animal models. Clin. Microbiol. Rev. 14:398-429.
195. Sandin, R. L., A. L. Rogers, R. J. Patterson, and E. S. Beneke. 1982. Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro. Infect. Immun. 35:79-85.
196. Sanglard, D., B. Hube, M. Monod, F. C. Odds, and N. A. Gow. 1997. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect. Immun. 65:3539-3546.
197. Santos, M. A., and M. F. Tuite. 1995. The CUG codon is decoded in vivo as serine and not leucine in Candida albicans. Nucleic Acids. Res. 23:1481-1486.
198. Sato, T., K. Nagai, M. Shibazaki, K. Abe, Y. Takebayashi, B. Lumanau, and R. M. Rantiatmodjo. 1994. Novel aspartyl protease inhibitors, YF-0200R-A and B. J. Antibiot. (Tokyo) 47:566-570.
199. Sato, T., M. Shibazaki, H. Yamaguchi, K. Abe, H. Matsumoto, and M. Shimizu. 1994. Novel Candida albicans aspartyl protease inhibitor. II. A new pepstatin-ahpatinin group inhibitor, YF-044P-D. J. Antibiot. 47:588-590.
200. Schaller, M., M. Bein, H. C. Korting, S. Baur, G. Hamm, M. Monod, S. Beinhauer, and B. Hube. 2003. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect. Immun. 71:3227-3234.
201. Schaller, M., B. Hube, M. W. Ollert, W. Schafer, v. Borg, M. Zepelin, E. Thoma-Greber, and H. C. Korting. 1999. In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J. Investig. Dermatol. 112:383-386.
202. Schaller, M., H. C. Korting, W. Schafer, J. Bastert, W. Chen, and B. Hube. 1999. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol. 34:169-180.
203. Schaller, M., C. Schackert, H. C. Korting, E. Januschke, and B. Hube. 2000. Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J. Investig. Dermatol. 114:712-717.
204. Schaller, M., W. Schäfer, H. C. Korting, and B. Hube. 1998. Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol. Microbiol. 29:605-615.
205. Schiodt, M. 1992. HIV-associated salivary gland disease: a review. Oral Surg. Oral Med. Oral Pathol. 73:164-167.
206. Schmid, J., F. C. Odds, M. J. Wiselka, K. G. Nicholson, and D. R. Soll, 1992. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J. Clin. Microbiol. 30:935-941.
207. Schroppel, K., K. Sprosser, M. Whiteway, Y. Thomas, M. Rollinghoff, and C. Csank. 2000. Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase cpp1p of Candida albicans is independent of the MAP kinase cek1p. Infect. Immun. 68:7159-7161.
208. Schweizer, A., S. Rupp, B. N. Taylor, M. Rollinghoff, and K. Schroppel. 2000. The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol. Microbiol. 38:435-445.
209. Shapiro, J. 1983. Mobile genetic elements. Academic Press, Inc., Orlando, Fla.
210. Smith, J. M., C. M. Tang, S. Van Noorden, and D. W. Holden. 1994. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Infect. Immun. 62:5247-5254.
211. Smithson, S. L., I. C. Paterson, A. M. Bailey, S. E. Screen, B. A. Hunt, B. D. Cobb, R. M. Cooper, A. K. Charnley; and J. M. Clarkson. 1995. Cloning and characterisation of a gene encoding a cuticle-degrading protease from the insect pathogenic fungus Metarhizium anisopliae. Gene 166:161-165.
212. Smolenski, G., P. A. Sullivan, S. M. Cutfield, and J. F. Cutfield. 1997. Analysis of secreted aspartic proteinases from Candida albicans: purification and characterization of individual Sap1, Sap2 and Sap3 isoenzymes. Microbiology 143:349-356.
213. Sobel, J. D. 1988. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann. N. Y. Acad. Sci. 544:547-557.
214. Sobel, J. D. 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis. 14(Suppl. 1):S148-S153.
215. Sohn, K., C. Urban, H. Brunner, and S. Rupp. 2003. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol. Microbiol. 47:89-102.
216. Soll, D. R. 1992. High-frequency switching in Candida albicans. Clin. Microbiol. Rev. 5:183-203.
217. Soll, D. R. 1997. Gene regulation during high-frequency switching in Candida albicans. Microbiology 143:279-288.
218. Soll, D. R. 2002. Phenotypic switching, p. 123-142. In R. A. Calderone (ed.), Candida and candidiasis. ASM Press, Washington, D.C.
219. Soll, D. R., B. Morrow, and T. Srikantha, 1993. High-frequency phenotypic switching in Candida albicans. Trends Genet. 9:61-65.
220. Soll, D. R., B. Morrow, T. Srikantha, K. Vargas, and P. Wertz. 1994. Developmental and molecular biology of switching in Candida albicans. Oral Surg. Oral Med. Oral Pathol. 78:194-201.
221. Srikantha, T., and D. R. Soll. 1993. A white-specific gene in the white-opaque switching system of Candida albicans. Gene 131:53-60.
222. Srikantha, T., L. Tsai, K. Daniels, A. J. Klar, and D. R. Soll. 2001. The histone deacetylase genes HDA1 and RPD3 play distinct roles in regulation of high-frequency phenotypic switching in Candida albicans. J. Bacteriol. 183:4614-4625.
223. Staab, J. F., and P. Sundstrom. 2003. URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol. 11:69-73.
224. Staib, F. 1965. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia 4:187-193.
225. Staib, P., M. Kretschmar, T. Nichterlein, H. Hof, and J. Morschhauser. 2000. Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. USA 97:6102-6107.
226. Staib, P., M. Kretschmar, T. Nichterlein, H. Hof, and J. Morschhauser. 2002. Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection. Infect. Immun. 70:921-927.
227. Staib, P., M. Kretschmar, T. Nichterlein, G. Kohler, S. Michel, H. Hof, J. Hacker, and J. Morschhauser. 1999. Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol. Microbiol. 32:533-546.
228. Stehr, F., A. Felk, M. Kretschmar, M. Schaller, W. Schafer, and B. Hube. 2000. Extracellular hydrolytic enzymes and their relevance during Candida albicans infections. Mycoses 43(Suppl. 2):17-21.
229. Stewart, K., and C. Abad-Zapatero. 2001. Candida proteases and their inhibition: prospects for antifungal therapy. Curr. Med. Chem. 8:941-948.
230. Stewart, K. W., R. C. Goldman, and C. Abad-Zapatero. 1999. The secreted proteinases from Candida: challenges for structure-aided drug design, p. 117-138. In B. M. Dunn (ed.), Proteases of infectious agents. Academic Press, Inc., San Diego, Calif.
231. Stoldt, V. R., A. Sonneborn, C. E. Leuker, and J. F. Ernst. 1997. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16:1982-1991.
232. Stringaro, A., P. Crateri, G. Pellegrini, G. Arancia, A. Cassone, and F. De Bernardis. 1997. Ultrastructural localization of the secretory aspartyl proteinase in Candida albicans cell wall in vitro and in experimentally infected rat vagina. Mycopathologia 137:95-105.
233. Sundstrom, P. 1999. Adhesins in Candida albicans. Curr. Opin. Microbiol. 2:353-357.
234. Sundstrom, P. 2002. Adhesion in Candida spp. Cell Microbiol. 4:461-469.
235. Sweet, S. P. 1997. Selection and pathogenicity of Candida albicans in HIV infection. Oral Dis. 3:S88-S95.
236. Sweet, S. P., S. J. Challacombe, and J. R. Naglik. 1995. Whole and parotid saliva IgA and IgA-subclass responses to Candida albicans in HIV infection. Adv. Exp. Med. Biol. 371B:1031-1034.
237. Togni, G., D. Sanglard, R. Falchetto, and M. Monod. 1991. Isolation and nucleotide sequence of the extracellular acid protease gene (ACP) from the yeast Candida tropicalis. FEBS Lett. 286:181-185.
238. Togni, G., D. Sanglard, M. Quadroni, S. I. Foundling, and M. Monod. 1996. Acid proteinase secreted by Candida tropicalis: functional analysis of preproregion cleavages in C. tropicalis and Saccharomyces cerevisiae. Microbiology 142:493-503.
239. Tsuboi, R., I. Ko, K. Takamori, and H. Ogawa. 1989. Isolation of a keratinolytic proteinase from Trichophyton mentagrophytes with enzymatic activity at acidic pH. Infect. Immun. 57:3479-3483.
240. Tsuboi, R., H. Ogawa, K. Bramono, M. D. Richardson, G. S. Shankland, W. J. Crozier, Y. Sei, J. Ninomiya, A. Nakabayashi, and I. Takaiuchi. 1994. Pathogenesis of superficial mycoses. J. Med. Vet. Mycol. 32(Suppl. 1):91-104.
241. Tsushima, H., H. Mine, Y. Kawakami, F. Hyodoh, and A. Ueki. 1994. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A. Microbiology 140:167-171.
242. Tzung, K. W., R. M. Williams, S. Scherer, N. Federspiel, T. Jones, N. Hansen, V. Bivolarevic, L. Huizar, C. Komp, R. Surzycki, R. Tamse, R. W. Davis, and N. Agabian. 2001. Genomic evidence for a complete sexual cycle in Candida albicans. Proc. Natl. Acad. Sci. USA 98:3249-3253.
243. Valdez, H., B. M. Gripshover, R. A. Salata, and M. M. Lederman. 1998. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy. AIDS 12:538.
244. Valdivia, R. H., and S. Falkow. 1997. Probing bacterial gene expression within host cells. Trends Microbiol. 5:360-363.
245. von Heijne, G. 1985. Signal sequences. The limits of variation. J. Mol. Biol. 184:99-105.
246. Vudhichamnong, K., D. M. Walker, and H. C. Ryley. 1982. The effect of secretory immunoglobulin A on the in-vitro adherence of the yeast Candida albicans to human oral epithelial cells. Arch. Oral Biol. 27:617-621.
247. Watts, H. J., F. S. Cheah, B. Hube, D. Sanglard, and N. A. Gow. 1998. Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol. Lett. 159:129-135.
248. Whelan, W. L., D. R. Kirsch, K. J. Kwon-Chung, S. M. Wahl, and P. D. Smith. 1990. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J. Infect. Dis. 162:513-518.
249. White, T. C., and N. Agabian. 1995. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J. Bacteriol. 177:5215-5221.
250. White, T. C., S. H. Miyasaki, and N. Agabian. 1993. Three distinct secreted aspartyl proteinases in Candida albicans. J. Bacteriol. 175:2997-3005.
251. White, T. C., M. A. Pfaller, M. G. Rinaldi, J. Smith, and S. W. Redding. 1997. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis. 3(Suppl 1):S102-S109.
252. Wood, V., R. Gwilliam, M. A. Rajandream, M. Lyne, R. Lyne, A. Stewart, J. Sgouros, N. Peat, J. Hayles, S. Baker, D. Basham, S. Bowman, K. Brooks, D. Brown, S. Brown, T. Chillingworth, C. Churcher, M. Collins, R. Connor, A. Cronin, P. Davis, T. Feltwell, A. Fraser, S. Gentles, A. Goble, N. Hamlin, D. Harris, J. Hidalgo, G. Hodgson, S. Holroyd, T. Hornsby, S. Howarth, E. J. Huckle, S. Hunt, K. Jagels, K. James, L. Jones, M. Jones, S. Leather, S. McDonald, J. McLean, P. Mooney, S. Moule, K. Mungall, L. Murphy, D. Niblett, C. Odell, K. Oliver, S. O'Neil, D. Pearson, M. A. Quail, E. Rabbinowitsch, K. Rutherford, S. Rutter, D. Saunders, K. Seeger, S. Sharp, J. Skelton, M. Simmonds, R. Squares, S. Squares, K. Stevens, K. Taylor, R. G. Taylor, A. Tivey, S. Walsh, T. Warren, S. Whitehead, J. Woodward, G. Volckaert, R. Aert, J. Robben, B. Grymonprez, I. Weltjens, E. Vanstreels, M. Rieger, M. Schafer, S. Muller-Auer, C. Gabel, M. Fuchs, C. Fritze, E. Holzer, D. Moestl, H. Hilbert, K. Borzym, I. Langer, A. Beck, H. Lehrach, R. Reinhardt, T. M. Pohl, P. Eger, W. Zimmermann, H. Wedler, R. Wambuttt, B. Purnelle, A. Goffeau, E. Cadieu, S. Dreano, S. Gloux, V. Lelaure, S. Mottier, F. Galibert, S. J. Aves, Z. Xiang, C. Hunt, K. Moore, S. M. Hurst, M. Lucas, M. Rochet, C. Gaillardin, V. A. Tallada, A. Garzon, G. Thode, R. R. Daga, L. Cruzado, J. Jimenez, M. Sanchez, F. del Rey, J. Benito, A. Dominguez, J. L. Revuelta, S. Moreno, J. Armstrong, S. L. Forsburg, L. Cerrutti, T. Lowe, W. R. McCombie, I. Paulsen, J. Potashkin, G. V. Shpakovski, D. Ussery, B. G. Barrell, and P. Nurse. 2002. The genome sequence of Schizosaccharomyces pombe. Nature 415:871-880.
253. Wright, R. J., A. Carne, A. D. Hieber, I. L. Lamont, G. W. Emerson, and P. A. Sullivan. 1992. A second gene for a secreted aspartate proteinase in Candida albicans. J. Bacteriol. 174:7848-7853.
254. Wu, T., and L. P. Samaranayake. 1999. The expression of secreted aspartyl proteinases of Candida species in human whole saliva. J. Med. Microbiol. 48:711-720.
255. Wu, T., L. P. Samaranayake, B. Y. Cao, and J. Wang. 1996. In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J. Med. Microbiol. 44:311-316.
256. Yuan, L., and G. T. Cole. 1987. Isolation and characterization of an extra-cellular proteinase of Coccidioides immitis. Infect. Immun. 55:1970-1978.
257. Zaugg, C., M. Borg-von Zepelin, D. Reichard, D. Sanglard, and M. Monod. 2001. Secreted aspartic proteinase family of Candida tropicalis. Infect. Immun. 69:405-412.
258. Zhang, Z., H. N. El Sohly, M. R. Jacob, D. S. Pasco, L. A. Walker, and A. M. Clark. 2002. Natural products inhibiting Candida albicans secreted aspartic proteases from Lycopodium cemuum. J. Nat. Prod. 65:979-985.
259. Zhang, Z., H. N. El Sohly, M. R. Jacob, D. S. Pasco, L. A. Walker, and A. M. Clark. 2002. Natural products inhibiting Candida albicans secreted aspartic proteases from Tovomita krukovii. Planta Med. 68:49-54.
260. Zhou, J., and J. H. Miller. 2002. Microbial genomics-challenges and opportunities: the 9th International Conference on Microbial Genomes. J. Bacteriol. 184:4327-4333.
261. Zotter, C., U. F. Haustein, C. Schonborn, H. D. Grimmecke, and H. Wand. 1990. Effect of pepstatin A on Candida albicans infection in the mouse. Dermatol. Monatsschrift 176:189-198.